Hologic, Inc. Recalls BioZorb Marker Due to Complications with Implanted Devices
The U.S. Food and Drug Administration (FDA) has issued a recall of the Hologic, Inc. BioZorb marker due to complications with implanted devices. The agency identified this as a Class I recall, the most serious type of recall. Details issued in a written notice by the FDA on May 22 and are shared here.
Source: itnonline.com